HEALTHCARE

January 20, 2020

ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask

ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market.

Full face CPAP users can now choose between"...

Read More >>

January 20, 2020

Obesity key to type 2 diabetes, which has quadrupled in the last 35 years

Abdulatif, a 73-year old man suffered from complex diabetes which led to kidney failure. Abdulatif, an Emirati by origin weighed 115 kgs and clearly suffered from obesity, a key factor that led to his condition. Research indicates that more than two billion people are overweight or obese"...

Read More >>

January 18, 2020

Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness

The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Eye Hospital, UK to develop the Foundation’s recently acquired proprietary technology"...

Read More >>

January 17, 2020

Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan

Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong.

The partnership covers Samsung Bioepis’ biosimilar"...

Read More >>

January 15, 2020

Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today at the 38th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, will share details on Takeda’s portfolio and pipeline strategy, financial outlook, and ongoing sustainability efforts, including its newly established commitment to carbon neutrality across its value chain. “Last year was an important and successful year for Takeda as we accelerated our transformation to become a leading global biopharmaceutical company,”......

Read More >>

January 15, 2020

Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Heska Corporation (“Heska”) (NASDAQ: HSKA) for a purchase price of $125"...

Read More >>

January 15, 2020

Cost Management Is the Scientific, Methodical and Process Driven Buzz Word for Sustainability in Healthcare Industry

The Cost Diagnosis

The medical industry is always advancing the accuracy of diagnosis for better treatment. A transition from a 64 slice CT scan to 128 and then 256 to 320 slice CT scan produces enhanced diagnosis"...

Read More >>

January 15, 2020

Fakih IVF welcomed over 8,000 patients with high success rates

Fakih IVF, one of the leading infertility centers in the GCC welcomed over 8,000 patients in the past year, demonstrating a success rate of 65%. To further extend their support to individuals battling infertility, the fertility center is running a campaign “New Year, New beginnings"...

Read More >>

January 15, 2020

GNT Pharma's Anti-dementia Drug 'crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia

GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease. In the clinical study conducted with 48 companion dogs with severe cognitive dysfunction at 7 veterinary hospitals including Seoul National University Animal Hospital, crisdesalazine-treated group demonstrated outstanding and significant efficacy compared to the placebo group in canine cognitive dysfunction rating scale, the primary outcome measure, as well as in canine dementia scale, the secondary outcome measure. Efficacy was identified both at the 4-week and 8-week......

Read More >>

January 14, 2020

BLEED OUT Documentary Screening and Panel Discussion

Patient Safety Movement Foundation: WHAT: After a routine partial hip replacement operation leaves his mother in a coma with permanent brain damage, a son’s video diary becomes a citizen’s investigation into American healthcare. Shot over the course of 10 years, using archival footage, verite scenes, undercover spy cams, courtroom testimony and interviews with family and experts, BLEED OUT goes deep inside the flawed healthcare system. WHY: Many Americans are unaware that preventable medical errors in hospitals are the third leading cause of death in the United States, behind only......

Read More >>

Found articles: - Pages